Clinical pain management: Current practice and recent innovations in research.

IF 11.7 1区医学 Q1 CELL BIOLOGY

Cell Reports Medicine Pub Date : 2024-10-15 Epub Date: 2024-10-08 DOI:10.1016/j.xcrm.2024.101786

Jing Wang, Lisa V Doan

引用次数: 0

Abstract

Chronic pain affects one in five adults. It is not only a major cause of disability for individual patients but also a driver of costs for entire healthcare systems. Treatment of pain remains a challenge, and the use of opioids has further led to a concurrent opioid epidemic. In this review, we discuss current standard treatment options for chronic pain, including pharmacological, behavioral, and interventional treatments. In addition, we review ongoing research in different areas that will potentially unlock new therapies.

查看原文本刊更多论文

临床疼痛管理：当前实践与最新研究创新。

慢性疼痛影响着五分之一的成年人。它不仅是导致患者残疾的主要原因，也是整个医疗保健系统成本的驱动因素。疼痛治疗仍然是一项挑战，阿片类药物的使用进一步导致了阿片类药物的流行。在这篇综述中，我们将讨论当前慢性疼痛的标准治疗方案，包括药物、行为和介入治疗。此外，我们还回顾了不同领域正在进行的研究，这些研究可能会推出新的疗法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cell Reports Medicine Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)

CiteScore

15.00

自引率

1.40%

发文量

231

审稿时长

40 days

期刊介绍： Cell Reports Medicine is an esteemed open-access journal by Cell Press that publishes groundbreaking research in translational and clinical biomedical sciences, influencing human health and medicine. Our journal ensures wide visibility and accessibility, reaching scientists and clinicians across various medical disciplines. We publish original research that spans from intriguing human biology concepts to all aspects of clinical work. We encourage submissions that introduce innovative ideas, forging new paths in clinical research and practice. We also welcome studies that provide vital information, enhancing our understanding of current standards of care in diagnosis, treatment, and prognosis. This encompasses translational studies, clinical trials (including long-term follow-ups), genomics, biomarker discovery, and technological advancements that contribute to diagnostics, treatment, and healthcare. Additionally, studies based on vertebrate model organisms are within the scope of the journal, as long as they directly relate to human health and disease.